Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arndt Hartmann

Showing results (721-730 of 933) with videos related to

Pageof 94
Sort By:
Cellular and Molecular Life Sciences : CMLS|September 22, 2023
Loss of ORP3 induces aneuploidy and promotes bladder cancer cell invasion through deregulated microtubule and actin dynamicsXue Wang, Junnan Liu, Anca Azoitei, et al.
Virchows Archiv : an International Journal of Pathology|April 8, 2026
Prognostic value of the tumor immune microenvironment, PD-L1 and p16<sup>INK4A</sup> in penile squamous cell carcinomaAugust Fiegl, Miriam Angeloni, Jan Mink, et al.
Cancers|October 14, 2023
Evaluation of Prognostic Parameters to Identify Aggressive Penile CarcinomasJan Niklas Mink, Oybek Khalmurzaev, Alexey Pryalukhin, et al.
Oncotarget|March 31, 2018
A multicenter round robin test of PD-L1 expression assessment in urothelial bladder cancer by immunohistochemistry and RT-qPCR with emphasis on prognosis prediction after radical cystectomyMarkus Eckstein, Ralph M Wirtz, Carolin Pfannstil, et al.
The American Journal of Pathology|April 22, 2021
Lipomatous Solitary Fibrous Tumors Harbor Rare NAB2-STAT6 Fusion Variants and Show Up-Regulation of the Gene PPARG, Encoding for a Regulator of Adipocyte DifferentiationFlorian Haller, Lea D Schlieben, Fulvia Ferrazzi, et al.
European Journal of Cancer (Oxford, England : 1990)|March 5, 2023
Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer - A single-arm phase II trial (NeoImmunoboost, AGO-B-041)Peter A Fasching, Alexander Hein, Hans-Christian Kolberg, et al.
The Journal of Clinical Investigation|January 31, 2020
Molecular crosstalk between Y5 receptor and neuropeptide Y drives liver cancerPeter Dietrich, Laura Wormser, Valerie Fritz, et al.
Human Pathology|October 13, 2014
The Fuhrman grading system has no prognostic value in patients with nonsarcomatoid chromophobe renal cell carcinomaSandra Steffens, Martin Janssen, Frederik C Roos, et al.
Molecular Therapy. Nucleic Acids|April 2, 2019
Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In VivoSven Wach, Madeleine Brandl, Hannes Borchardt, et al.
Breast Cancer Research and Treatment|February 28, 2015
Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trialRamona Erber, Oleg Gluz, Nils Brünner, et al.
Pageof 94

Showing results (721-730 of 933) with videos related to

Sort By:
Pageof 94
Cellular and Molecular Life Sciences : CMLS|September 22, 2023
Loss of ORP3 induces aneuploidy and promotes bladder cancer cell invasion through deregulated microtubule and actin dynamicsXue Wang, Junnan Liu, Anca Azoitei, et al.
Virchows Archiv : an International Journal of Pathology|April 8, 2026
Prognostic value of the tumor immune microenvironment, PD-L1 and p16<sup>INK4A</sup> in penile squamous cell carcinomaAugust Fiegl, Miriam Angeloni, Jan Mink, et al.
Cancers|October 14, 2023
Evaluation of Prognostic Parameters to Identify Aggressive Penile CarcinomasJan Niklas Mink, Oybek Khalmurzaev, Alexey Pryalukhin, et al.
Oncotarget|March 31, 2018
A multicenter round robin test of PD-L1 expression assessment in urothelial bladder cancer by immunohistochemistry and RT-qPCR with emphasis on prognosis prediction after radical cystectomyMarkus Eckstein, Ralph M Wirtz, Carolin Pfannstil, et al.
The American Journal of Pathology|April 22, 2021
Lipomatous Solitary Fibrous Tumors Harbor Rare NAB2-STAT6 Fusion Variants and Show Up-Regulation of the Gene PPARG, Encoding for a Regulator of Adipocyte DifferentiationFlorian Haller, Lea D Schlieben, Fulvia Ferrazzi, et al.
European Journal of Cancer (Oxford, England : 1990)|March 5, 2023
Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer - A single-arm phase II trial (NeoImmunoboost, AGO-B-041)Peter A Fasching, Alexander Hein, Hans-Christian Kolberg, et al.
The Journal of Clinical Investigation|January 31, 2020
Molecular crosstalk between Y5 receptor and neuropeptide Y drives liver cancerPeter Dietrich, Laura Wormser, Valerie Fritz, et al.
Human Pathology|October 13, 2014
The Fuhrman grading system has no prognostic value in patients with nonsarcomatoid chromophobe renal cell carcinomaSandra Steffens, Martin Janssen, Frederik C Roos, et al.
Molecular Therapy. Nucleic Acids|April 2, 2019
Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In VivoSven Wach, Madeleine Brandl, Hannes Borchardt, et al.
Breast Cancer Research and Treatment|February 28, 2015
Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trialRamona Erber, Oleg Gluz, Nils Brünner, et al.
Pageof 94